SFG
GILD icon

SNS Financial Group’s Gilead Sciences GILD Stock Holding History

SNS Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-600
Closed -$43K – 229
2016
Q4 		$43K Buy
+600
New +$44.6K 0.01% 188
2015
Q1 		– Sell
-2,200
Closed -$222K – 119
2014
Q4 		$222K Buy
+2,200
New +$228K 0.09% 100

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SNS Financial Group's GILD Position: Q1 2023 in Review

SNS Financial Group sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 4,126 shares — an estimated $354K sold.

SNS Financial Group first reported a position in GILD in Q2 2015 and held it in 29 quarters. The position peaked at $4.37M in Q4 2015. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • SNS Financial Group reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • SNS Financial Group sold 4,126 Gilead Sciences shares in Q1 2023, an estimated $354K.
  • SNS Financial Group first reported a position in Gilead Sciences in Q2 2015 and held it in 29 quarters.
  • SNS Financial Group's Gilead Sciences position peaked at $4.37M in Q4 2015.
  • 1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on SNS Financial Group's 13F filing for Q1 2023, filed 28 Apr 2023.